These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 10844109
21. Hemodynamic profile of SKP-450, a new potassium-channel activator. Lee BH, Yoo SE, Shin HS. J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282 [Abstract] [Full Text] [Related]
22. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury. Lee SH, Yang MK, Lim JH, Seo HW, Yi KY, Yoo SE, Lee BH, Won HS, Lee CS, Choi WS, Shin HS. Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506 [Abstract] [Full Text] [Related]
23. [Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation]. Bogomaz SA, Maslov LN, Krylatov AV, Solenkova NV, Lishmanov AIu, Budankova EV, Grover GJ. Ross Fiziol Zh Im I M Sechenova; 2003 Apr; 89(4):409-19. PubMed ID: 12966718 [Abstract] [Full Text] [Related]
24. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. Baczkó I, Leprán I, Papp JG. Eur J Pharmacol; 1997 Apr 11; 324(1):77-83. PubMed ID: 9137916 [Abstract] [Full Text] [Related]
25. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle. Venkatesh N, Stuart JS, Lamp ST, Alexander LD, Weiss JN. Circ Res; 1992 Dec 11; 71(6):1324-33. PubMed ID: 1423930 [Abstract] [Full Text] [Related]
26. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA, Atwal KS. J Cardiovasc Pharmacol; 1995 Jan 11; 25(1):40-50. PubMed ID: 7723352 [Abstract] [Full Text] [Related]
27. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Das B, Sarkar C. Life Sci; 2005 Jul 29; 77(11):1226-48. PubMed ID: 15964023 [Abstract] [Full Text] [Related]
28. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim. Gross GJ, Mei DA, Sleph PG, Grover GJ. J Pharmacol Exp Ther; 1997 Feb 29; 280(2):533-40. PubMed ID: 9023261 [Abstract] [Full Text] [Related]
29. Involvement of ATP-sensitive potassium channels in a model of a delayed vascular hyporeactivity induced by lipopolysaccharide in rats. Sorrentino R, d'Emmanuele di Villa Bianca R, Lippolis L, Sorrentino L, Autore G, Pinto A. Br J Pharmacol; 1999 Jul 29; 127(6):1447-53. PubMed ID: 10455295 [Abstract] [Full Text] [Related]
30. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. Fryer RM, Hsu AK, Nagase H, Gross GJ. J Pharmacol Exp Ther; 2000 Aug 29; 294(2):451-7. PubMed ID: 10900218 [Abstract] [Full Text] [Related]
31. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats. Shin HS, Seo HW, Oh JH, Lee BH. Arzneimittelforschung; 1998 Oct 29; 48(10):969-78. PubMed ID: 9825113 [Abstract] [Full Text] [Related]
32. Cardiovascular effects of the novel potassium channel opener UR-8225. Tamargo J, Pérez O, Delpón E, García-Rafanell J, Gómez L, Cavalcanti F. J Cardiovasc Pharmacol; 1995 Aug 29; 26(2):295-305. PubMed ID: 7475055 [Abstract] [Full Text] [Related]
33. Selective mitochondrial K(ATP) channel activation results in antiarrhythmic effect during experimental myocardial ischemia/reperfusion in anesthetized rabbits. Das B, Sarkar C, Karanth KS. Eur J Pharmacol; 2002 Feb 22; 437(3):165-71. PubMed ID: 11890905 [Abstract] [Full Text] [Related]
34. Thiopental and propofol impair relaxation produced by ATP-sensitive potassium channel openers in the rat aorta. Kinoshita H, Ishida K, Ishikawa T. Br J Anaesth; 1998 Nov 22; 81(5):766-70. PubMed ID: 10193292 [Abstract] [Full Text] [Related]
35. The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation. Ng CF, Koon CM, Cheung DW, Lam MY, Leung PC, Lau CB, Fung KP. J Ethnopharmacol; 2011 Oct 11; 137(3):1366-72. PubMed ID: 21855622 [Abstract] [Full Text] [Related]
36. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts. D'Alonzo AJ, Grover GJ, Darbenzio RB, Sewter JC, Hess TA, Dzwonczyk S, Sleph PG. Pharmacology; 1996 Feb 11; 52(2):101-12. PubMed ID: 8851631 [Abstract] [Full Text] [Related]
37. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits. Das B, Sarkar C, Karanth KS. Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov 11; 364(5):383-96. PubMed ID: 11692221 [Abstract] [Full Text] [Related]
38. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Ferdinandy P, Szilvássy Z, Droy-Lefaix MT, Tarrade T, Koltai M. Cardiovasc Res; 1995 Nov 11; 30(5):781-7. PubMed ID: 8595627 [Abstract] [Full Text] [Related]
39. Cardioprotective effects of (2S,3R,4S)-N'-benzyl-N"-cyano-N-(3,4-dihydro-2-dimethoxymethyl-3-hydroxy-2-methyl-6-nitro-2H-benzopyran-4-yl)-guanidine (KR-31372) in rats and dogs. Lee BH, Seo HW, Yoo SE. Pharmacology; 2004 Feb 11; 70(2):74-82. PubMed ID: 14685010 [Abstract] [Full Text] [Related]
40. Effects of ATP-dependent K+ channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation. Bellemin-Baurreau J, Poizot A, Hicks PE, Rochette L, Armstrong JM. Eur J Pharmacol; 1994 Apr 21; 256(2):115-24. PubMed ID: 8050462 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]